Related Experiment Video
Updated: Jun 19, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese
Lei Cui1, Haiying Zhou, Jie Yu
1Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.
Insights
A specific variant in the complement factor H (CFH) gene, rs1410996, is linked to increased risk of exudative age-related macular degeneration (AMD) in Chinese patients. Complement component 3 (C3) gene variants showed no association with AMD in this population.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
- Genetic factors, including variants in complement genes, are implicated in AMD pathogenesis.
- The role of specific complement factor H (CFH) and complement component 3 (C3) gene variants in exudative AMD among Chinese populations requires further investigation.
Purpose of the Study:
- To determine the association between a noncoding variant of the CFH gene (rs1410996) and two coding variants of the C3 gene (rs2230199, rs1047286) with exudative AMD.
- To evaluate the genetic risk factors for exudative AMD in a Chinese cohort.
Main Methods:
- Genotyping of CFH (rs1410996) and C3 (rs2230199, rs1047286) variants using PCR and direct sequencing.
- Case-control study involving 150 Chinese patients with exudative AMD and 161 controls.
Main Results:
- The CFH noncoding variant rs1410996 was significantly associated with exudative AMD (P < 0.001).
- Carriers of the risk C allele at rs1410996 had an increased odds ratio for AMD, particularly homozygous CC genotype (OR=3.85).
- C3 variants rs2230199 and rs1047286 were rare and not associated with exudative AMD in this cohort.
Conclusions:
- The CFH noncoding variant rs1410996 is a risk factor for exudative AMD in the Chinese population.
- C3 gene variants rs2230199 and rs1047286 do not appear to contribute to exudative AMD risk in this Chinese cohort.
Purpose:
To investigate whether the previously reported noncoding variant of the complement factor H (CFH) gene and two coding variants of the complement component 3 (C3) gene are associated with exudative age-related macular degeneration (AMD) in Chinese patients.
Methods:
One hundred fifty Chinese patients with exudative AMD and 161 control individuals without AMD were recruited for the study. Genomic DNA was extracted from blood leukocytes. The noncoding variant of the CFH gene (rs1410996) and two coding variants of the C3 gene (rs2230199 and rs1047286) were genotyped by polymerase chain reaction (PCR) followed by allele-specific restriction enzyme digestion and direct sequencing.
Results:
Significant association was detected for exudative AMD with the CFH noncoding variant rs1410996. Frequencies of the risk C allele at rs1410996 were 72.0% in AMD cases versus 55.6% in controls (P < 0.001). The odds ratio for risk of AMD was 1.71 (95% confidence interval [CI], 0.82-3.54) for heterozygous TC genotype and 3.85 (95% CI, 1.84-8.05) for homozygous CC genotype compared with the wild TT genotype. In contrast, the C3 variants rs2230199 and rs1047286 were not associated with exudative AMD in the studied subjects. Frequencies of the risk G allele at rs2230199 and of the risk T allele at rs1047286 were 0.3% to 1.0% in both cases and controls.
Conclusions:
The data suggest that the noncoding variant rs1410996 of the CFH gene moderately increased the risk of exudative AMD in a Chinese population. The C3 variants were rare and not associated with exudative AMD in this Chinese cohort.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Genetic Lingo
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Principles of Pharmacogenetics: Types of Genetic Variants

